TickerFacts.

Stemtech Corp (STEK): R&D Expense

Annual figures by period end, from SEC filings.

$0
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
$13.8K2020-12-31: $7502022-12-31: $02023-12-31: $13.8K2024-12-31: $02025-12-31: $0$0
2020-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$0n/a2026-05-29, From 2025-01-01
2024-12-31$0-100.0%2026-05-29, From 2024-01-01
2023-12-31$13.8Kn/a2024-07-10, From 2023-01-01
2022-12-31$0n/a2024-07-10, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31$750n/a2022-04-01, From 2020-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Stemtech Corp (STEK)2025-12-31$0n/a
Cosmos Health Inc. (COSM)2025-12-31$519.4K-2.6%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$10.80M-16.9%

Compare STEK, COSM, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗